H19 and neoplasm: Thirty days after subcutaneous injection, the tumors formed in H19-siRNA and si-TNFAIP8 groups were substantially smaller than those in the negative control group, as evidenced by a dramatic decrease in tumor volume and tumor weight (Fig. 6a, b).